{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:08:59Z","timestamp":1784628539974,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Norwegian Resource Centre for ADHD, Tourette syndrome and Narcolepsy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00228-016-2125-y","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T17:38:46Z","timestamp":1472837926000},"page":"1507-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Use of drugs for ADHD among adults\u2014a multinational study among 15.8 million adults in the Nordic countries"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1204-787X","authenticated-orcid":false,"given":"\u00d8ystein","family":"Karlstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zo\u00ebga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Furu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Bahmanyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana E","family":"Martikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Kieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"1","key":"2125_CR1","doi-asserted-by":"crossref","first-page":"c549","DOI":"10.1136\/bmj.c549","volume":"340","author":"P Asherson","year":"2010","unstructured":"Asherson P, Adamou M, Bolea B, Muller U, Morua SD, Pitts M, Thome J, Young S (2010) Is ADHD a valid diagnosis in adults? Yes. BMJ 340(1):c549","journal-title":"BMJ"},{"issue":"1","key":"2125_CR2","doi-asserted-by":"crossref","first-page":"c547","DOI":"10.1136\/bmj.c547","volume":"340","author":"J Moncrieff","year":"2010","unstructured":"Moncrieff J, Timimi S (2010) Is ADHD a valid diagnosis in adults? No. BMJ 340(1):c547","journal-title":"BMJ"},{"key":"2125_CR3","unstructured":"Schwarz A. The Selling of Attention Deficit Disorder. The New York Times [Internet]. 2013 [cited 2015 Sep 10]; Available from: www.nytimes.com\/2013\/12\/15\/health\/the-selling-of-attention-deficit-disorder"},{"issue":"5","key":"2125_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1192\/bjp.bp.113.126474","volume":"203","author":"PJ Shah","year":"2013","unstructured":"Shah PJ, Morton MJS (2013) Adults with attention-deficit hyperactivity disorder - diagnosis or normality? Br J Psychiatry 203(5):317\u2013319","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2125_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36(2):159\u2013165","journal-title":"Psychol Med"},{"issue":"4","key":"2125_CR6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Berkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716\u2013723","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2125_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.psychres.2009.12.010","volume":"177","author":"J Biederman","year":"2010","unstructured":"Biederman J, Petty CR, Evans M, Small J, Faraone SV (2010) How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 177(3):299\u2013304","journal-title":"Psychiatry Res"},{"key":"2125_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-244X-10-67","volume":"10","author":"SJ Kooij","year":"2010","unstructured":"Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugu\u00e9 M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M, Gaillac V, Ginsberg Y, Henry C, Krause J, Lensing MB, Manor I, Niederhofer H, Nunes-Filipe C, Ohlmeier MD, Oswald P, Pallanti S, Pehlivanidis A, Ramos-Quiroga JA, Rastam M, Ryffel-Rawak D, Stes S, Asherson P (2010) European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 10:67","journal-title":"BMC Psychiatry"},{"issue":"9","key":"2125_CR9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1185\/03007995.2013.812961","volume":"29","author":"JA Ramos-Quiroga","year":"2013","unstructured":"Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E (2013) Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 29(9):1093\u20131104","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2125_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4088\/JCP.10m06628","volume":"73","author":"A Turgay","year":"2012","unstructured":"Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R, ADHD Transition Phase Model Working Group (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2):192\u2013201","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2125_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12402-012-0077-3","volume":"4","author":"B Matte","year":"2012","unstructured":"Matte B, Rohde LA, Grevet EH (2012) ADHD in adults: a concept in evolution. ADHD Atten Deficit Hyperact Disord 4(2):53\u201362","journal-title":"ADHD Atten Deficit Hyperact Disord"},{"issue":"5","key":"2125_CR12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","volume":"190","author":"J Fayyad","year":"2007","unstructured":"Fayyad J, Graaf RD, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, Girolamo GD, Haro JM, Karam EG, Lara C, L\u00e9pine J-P, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross\u2013national prevalence and correlates of adult attention\u2013deficit hyperactivity disorder. Br J Psychiatry 190(5):402\u2013409","journal-title":"Br J Psychiatry"},{"issue":"4","key":"2125_CR13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/YCO.0b013e3281568d7a","volume":"20","author":"G Polanczyk","year":"2007","unstructured":"Polanczyk G, Rohde LA (2007) Epidemiology of attention-deficit\/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 20(4):386\u2013392","journal-title":"Curr Opin Psychiatry"},{"issue":"5","key":"2125_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/ps.62.5.pss6205_0459","volume":"62","author":"SP Hinshaw","year":"2011","unstructured":"Hinshaw SP, Scheffler RM, Fulton BD, Aase H, Banaschewski T, Cheng W, Mattos P, Holte A, Levy F, Sadeh A, et al. (2011) International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv 62(5):459\u2013464","journal-title":"Psychiatr Serv"},{"key":"2125_CR15","doi-asserted-by":"crossref","unstructured":"Giacobini M, Medin E, Ahnemark E, Russo LJ, Carlqvist P. Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden. J Atten Disord. 2014;1087054714554617","DOI":"10.1177\/1087054714554617"},{"key":"2125_CR16","unstructured":"Helsedirektoratet. ADHD\/hyperkinetisk forstyrrelse \u2013 nasjonal faglig retningslinje for utredning, behandling og oppf\u00f8lging [In Norwegian] [Internet]. 2014. Report No.: IS-2062. Available from: https:\/\/helsedirektoratet.no\/retningslinjer\/adhd"},{"key":"2125_CR17","unstructured":"Sundhedsstyrelsen. National klinisk retningslinje for udredning og behandling af ADHD hos voksne [In Danish] [Internet]. Sundhedsstyrelsen; 2015. Available from: https:\/\/sundhedsstyrelsen.dk\/da\/udgivelser\/2015\/nkr-adhd-hos-voksne"},{"key":"2125_CR18","unstructured":"Socialstyrelsen. L\u00e4kemedelsbehandling av adhd hos barn och vuxna \u2013 St\u00f6d f\u00f6r beslut om behandling [In Swedish] [Internet]. 2015. Available from: http:\/\/www.socialstyrelsen.se\/publikationer2015\/2015-4-14"},{"key":"2125_CR19","unstructured":"Emb\u00e6tti landl\u00e6knis. Vinnulag vi\u00f0 greiningu og me\u00f0fer\u00f0 athyglisbrests me\u00f0 ofvirkni (ADHD) \u2013 Stytt \u00fatg\u00e1fa lei\u00f0beininga [In Icelandic] [Internet]. 2014. Available from: http:\/\/www.landlaeknir.is\/gaedi-og-eftirlit\/heilbrigdisstarfsfolk\/klininskar-leidbeiningar\/leidbeiningar\/item14931\/ADHD---vinnulag-vid-greiningu-og-medferd"},{"issue":"4","key":"2125_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/14740338.2015.1011620","volume":"14","author":"PG Hammerness","year":"2015","unstructured":"Hammerness PG, Karampahtsis C, Babalola R, Alexander ME (2015) Attention-deficit\/hyperactivity disorder treatment: what are the long-term cardiovascular risks? Expert Opin Drug Saf 14(4):543\u2013551","journal-title":"Expert Opin Drug Saf"},{"key":"2125_CR21","unstructured":"Statens beredning f\u00f6r medicinsk utv\u00e4rdering (SBU). ADHD - diagnostik och behandling, v\u00e5rdens organisation och patientens delaktighet \u2013 En systematisk litteratur\u00f6versikt [In Swedish] [Internet]. 2013. Report No.: 217. Available from: http:\/\/www.sbu.se\/sv\/Publicerat\/Gul\/ADHD---diagnostik-och-behandling-vardens-organisation-och-patientens-delaktighet\/"},{"issue":"20","key":"2125_CR22","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMcp1212625","volume":"369","author":"ND Volkow","year":"2013","unstructured":"Volkow ND, Swanson JM (2013) Adult attention deficit\u2013hyperactivity disorder. N Engl J Med 369(20):1935\u20131944","journal-title":"N Engl J Med"},{"issue":"4","key":"2125_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1087054707299597","volume":"10","author":"L Castle","year":"2007","unstructured":"Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS (2007) Trends in medication treatment for ADHD. J Atten Disord 10(4):335\u2013342","journal-title":"J Atten Disord"},{"issue":"1","key":"2125_CR24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2431-12-78","volume":"12","author":"S McCarthy","year":"2012","unstructured":"McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC (2012) The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr 12(1):78","journal-title":"BMC Pediatr"},{"issue":"1","key":"2125_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/cap.2008.0153","volume":"20","author":"E Ban van den","year":"2010","unstructured":"van den Ban E, Souverein P, Swaab H, van Engeland H, Heerdink R, Egberts T (2010) Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001\u20132006. J Child Adolesc Psychopharmacol 20(1):55\u201361","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"2125_CR26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/0004867414538675","volume":"48","author":"EA Karanges","year":"2014","unstructured":"Karanges EA, Stephenson CP, McGregor IS (2014) Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009 to 2012: focus on children, adolescents and prescriber specialty. Aust N Z J Psychiatry 48(10):917\u2013931","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"2125_CR27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT (2010) The Nordic countries as a cohort for Pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 106(2):86\u201394","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"2125_CR28","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2016 [Internet]. Oslo, Norway; 2015. Available from: http:\/\/www.whocc.no \/"},{"issue":"4","key":"2125_CR29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/pds.1304","volume":"16","author":"H Tobi","year":"2007","unstructured":"Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT (2007) Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 16(4):405\u2013411","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"2125_CR30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0447.2010.01607.x","volume":"123","author":"H Zoega","year":"2011","unstructured":"Zoega H, Furu K, Halld\u00f3rsson M, Thomsen PH, Sourander A, Martikainen JE (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123(5):360\u2013367","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"2125_CR31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.clinthera.2012.02.021","volume":"34","author":"KA Lawson","year":"2012","unstructured":"Lawson KA, Johnsrud M, Hodgkins P, Sasan\u00e9 R, Crismon ML (2012) Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther 34(4):944\u201356.e4","journal-title":"Clin Ther"},{"issue":"4","key":"2125_CR32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1185\/03007991003673617","volume":"26","author":"L Christensen","year":"2010","unstructured":"Christensen L, Sasan\u00e9 R, Hodgkins P, Harley C, Tetali S (2010) Pharmacological treatment patterns among patients with attention-deficit\/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 26(4):977\u2013989","journal-title":"Curr Med Res Opin"},{"issue":"16","key":"2125_CR33","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4045\/tidsskr.11.1270","volume":"132","author":"PKS Lillemoen","year":"2012","unstructured":"Lillemoen PKS, Kjosavik SR, Hunsk\u00e5r S, Ruths S (2012) Prescriptions for ADHD medication, 2004\u2009\u2013\u200908. Tidsskr Nor Laegeforen 132(16):1856\u20131860","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"10","key":"2125_CR34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00228-012-1265-y","volume":"68","author":"A Potteg\u00e5rd","year":"2012","unstructured":"Potteg\u00e5rd A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI (2012) The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol 68(10):1443\u20131450","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2125_CR35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/08039488.2011.593102","volume":"66","author":"N Bilenberg","year":"2012","unstructured":"Bilenberg N, Gillberg C, Houmann T, Kadesj\u00f8 B, Lensing MB, Plessen KJ, Strand G, Thomsen PH, Worning A (2012) Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines. Nord J Psychiatry 66(1):70\u201371","journal-title":"Nord J Psychiatry"},{"issue":"2","key":"2125_CR36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2011.11030387","volume":"169","author":"SH Zuvekas","year":"2012","unstructured":"Zuvekas SH, Vitiello B (2012) Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 169(2):160\u2013166","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2125_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bcpt.12243","volume":"115","author":"DP Geirs","year":"2014","unstructured":"Geirs DP, Potteg\u00e5rd A, Halld\u00f3rsson M, Zo\u00ebga H (2014) A Nationwide study of attention-deficit\/hyperactivity disorder drug use among adults in Iceland 2003\u20132012. Basic Clin Pharmacol Toxicol. 115(5):417\u2013422","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"4","key":"2125_CR38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12402-010-0044-9","volume":"2","author":"E Ban van den","year":"2010","unstructured":"van den Ban E, Souverein PC, Swaab H, van Engeland H, Egberts TCG, Heerdink ER (2010) Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45\u00a0years in the Netherlands. Atten Deficit Hyperact Disord 2(4):213\u2013220","journal-title":"Atten Deficit Hyperact Disord"},{"issue":"4","key":"2125_CR39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bcpt.12325","volume":"116","author":"A Potteg\u00e5rd","year":"2015","unstructured":"Potteg\u00e5rd A, Bjerregaard BK, Kortegaard LS, Zo\u00ebga H (2015) Early discontinuation of attention-deficit\/hyperactivity disorder drug treatment: a Danish Nationwide drug utilization study. Basic Clin Pharmacol Toxicol 116(4):349\u2013353","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2125_CR40","unstructured":"Aanonsen N, Lensing MB, Prietz R, G\u00f8rvell P, Sandven I, Lj\u00f8ner L. Utpr\u00f8vende behandling med sentralstimulerende legemidler til voksne med hyperkinetisk forstyrrelse\/ADHD [In Norwegian]. Ullev\u00e5l universitetssykehus; 2004."},{"issue":"6","key":"2125_CR41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/cch.12107","volume":"40","author":"KD Swift","year":"2014","unstructured":"Swift KD, Sayal K, Hollis C (2014) ADHD and transitions to adult mental health services: a scoping review. Child Care Health Dev 40(6):775\u2013786","journal-title":"Child Care Health Dev"},{"key":"2125_CR42","doi-asserted-by":"crossref","first-page":"e4627","DOI":"10.1136\/bmj.e4627","volume":"345","author":"AG Winterstein","year":"2012","unstructured":"Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M (2012) Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 345:e4627","journal-title":"BMJ"},{"issue":"24","key":"2125_CR43","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","volume":"306","author":"LA Habel","year":"2011","unstructured":"Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (2011) ADHD Medications and Risk of Serious Cardiovascular Events In Young and Middle-Aged Adults. JAMA 306(24):2673\u20132683","journal-title":"JAMA"},{"key":"2125_CR44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2261-12-41","volume":"12","author":"AN Westover","year":"2012","unstructured":"Westover AN, Halm EA (2012) Do prescription stimulants increase the risk of adverse cardiovascular events?: a systematic review. BMC Cardiovasc Disord 12:41","journal-title":"BMC Cardiovasc Disord"},{"issue":"20","key":"2125_CR45","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","volume":"365","author":"WO Cooper","year":"2011","unstructured":"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O\u2019Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365(20):1896\u20131904","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2125-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:55:32Z","timestamp":1498326932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2125-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2125-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]}}}